CS
APGE icon

Credit Suisse’s Apogee Therapeutics APGE Stock Holding History

Credit Suisse’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		$1.18M Buy
17,686
+2,949
+20% +$196K ﹤0.01% 2163
2023
Q4 		$412K Buy
+14,737
New +$412K ﹤0.01% 2805